EFTA00835154
EFTA00835155 DataSet-9
EFTA00835157

EFTA00835155.pdf

DataSet-9 2 pages 478 words document
P17 V11 V16 P21 P19
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (478 words)
From: Richard Kahn fr-" To: Jeffrey Epstein <[email protected]> Subject: Fwd: Mort Series 8 Timeline Date: Thu, 04 Feb 2016 20:06:43 +0000 attached was sent by Andrew Lindsay of Jawbone before i could send email to them that you and i discussed yesterday shall i still send email requesting money back or pass? andrew said in previous call that they were interviewing bankers to explore options.. please advise thank you Richard Kahn HBRK Associates Inc. 575 Lexington Avenue 4th Floor New York, NY 10022 tel fax cell Begin forwarded message: From: Andrew Lindsay < > Subject: Mort Series 8 Timeline Date: February 4, 2016 at 12:33:45 PM EST To: Richard Kahn Richard, Below is the Series 8 Timeline per your request. Feel free to let me know if you have any questions. Some of the details may not be relevant but I didn't want to leave anything out. During the month of July 2015, Jawbone negotiated the terms of the Series 8 financing with JPMorgan and Sequoia Capital. On July 21, 2015, BlackRock invested $50M in the Company. The terms of this investment required Jawbone to raise at least $40M in equity financing by July 24th and also allowed Jawbone to pull in another $50M from BlackRock if Jawbone raised an additional $35M in equity financing by August 31st. The initial Series 8 closing ($40M from JPMorgan and Sequoia) was completed on July 24, 2015. Beginning in mid-August 2015, Jawbone contacted major investors sharing the opportunity to invest in Jawbone Series 8 shares on the same terms as JPMorgan and Sequoia, with the objective of raising at least $35M by August 31st. Jawbone e-mailed Mort on August 13th about this opportunity. Some investors chose to commit to purchasing Series 8 shares contingent upon Jawbone raising the full $35M, and some of these investors placed their funds in a trust account held by Cooley LLP. EFTA00835155 Jawbone completed a second Series 8 closing ($5.9M from several investors) on August 31st but did not raise the full $35M by the August 31st deadline. On October 2, 2015, Jawbone received a commitment from Mort to purchase 228,757 Jawbone Series 8 Preferred Shares for $1,249,996.88. Mort wired its funds to Jawbone in anticipation of the closing of this investment. Jawbone did not close on Mort's Series 8 investment round at that time and the Company did not use the funds. Jawbone is holding Mort's funds as an advance pending closing of its Series 8 investment. Jawbone completed a third Series 8 closing ($15M from JPMorgan and Sequoia) on December 23, 2015 and a fourth closing ($0.5M from one investor) on February 3, 2016. Jawbone is now seeking to close on the remaining Series 8 investment. Given the length of time between Mort's commitment to invest and the closing, Jawbone is asking for Mort's authorization to release the funds for the Company's use. EFTA00835156
ℹ️ Document Details
SHA-256
e567d4ce16de916b1e35c8009c9d9319c49b71fbe662534f9d4c1f8ee4d51d13
Bates Number
EFTA00835155
Dataset
DataSet-9
Document Type
document
Pages
2

Comments 0

Loading comments…
Link copied!